™
THOSE DANG HORMONES
Estrogen, Connective Tissue, Mast Cells, & the Autonomic Plot Twist
In earlier Floppy Files discussions, we explored how infections and immune shifts can push already sensitive biological systems into chaos.
Another pattern keeps surfacing in those same conversations.
Puberty.
Pregnancy.
Perimenstrual flares.
The timeline is almost suspiciously tidy.
Symptoms spike when hormones shift.
They settle when hormones stabilize.
They flare when estrogen surges or drops.
This rhythm appears often enough that it deserves a closer look rather than a casual dismissal.
The question is not whether people notice the pattern.
The question is what estrogen might actually be doing.
Estrogen is often introduced as a reproductive hormone. In reality it behaves more like a regulatory signal that travels throughout the entire body.
Connective tissue is one of its quiet but important targets.
Ligaments, tendons, and fascia are built from collagen fibers arranged in dense structural bundles. These fibers are not static cables. They exist inside a constantly active remodeling system. Old collagen is broken down while new fibers are produced, aligned, and strengthened.
Research examining extracellular matrix regulation demonstrates that estrogen influences collagen synthesis, collagen turnover, and the mechanical properties of connective tissue.¹
Imagine connective tissue as the suspension cables of a bridge. The fibers must remain strong enough to stabilize the structure while flexible enough to absorb movement. Hormonal signals influence how tightly those cables are woven and how quickly they are replaced.
Estrogen alters fibroblast behavior, the cells responsible for building collagen. It also influences enzymes that break down older fibers.
Now introduce another hormone that frequently travels alongside estrogen.
Relaxin.
Relaxin rises during parts of the menstrual cycle and increases significantly during pregnancy. A 2024 systematic review examining hormonal effects on ligament vulnerability highlighted relaxin’s collagen softening properties and its association with windows of increased ligament laxity.²
Relaxin’s biological role is straightforward. It loosens connective tissue so the pelvis can expand during childbirth.
In pregnancy, that flexibility is essential.
In a body where connective tissue is already fragile, the same biochemical signal may increase joint laxity and instability.
Hormones do not create connective tissue disorders.
They can amplify the mechanical consequences when connective tissue integrity is already delicate.
A structure under tension rarely needs a dramatic shove.
A small shift can change everything.
Mast cells serve as the immune system’s neighborhood sentinels.
They sit along blood vessels, nerves, and mucosal surfaces, packed with inflammatory mediators such as histamine, prostaglandins, and cytokines. When triggered, they release these chemicals rapidly, producing swelling, vascular changes, and immune signaling.
Hormones appear to influence this process.
Emerging research suggests estrogen can affect mast cell recruitment and activation. A study recently demonstrated that estrogen increased mast cell presence and inflammatory mediator activity in experimental models of endometriosis.³
This study did not investigate mast cell activation syndrome directly.
It does show that estrogen can enhance mast cell mediated inflammation within living biological systems.
Clinical observations often echo this biology. Many individuals who experience mast cell related symptoms report changes during hormonal transitions:
Perimenstrual flares
Shifts during pregnancy
New allergic patterns emerging around puberty
These observations align with known immune signaling pathways. Estrogen interacts with cytokine networks and alters vascular permeability. Mast cells operate directly within that vascular environment.
If mast cells are already inclined toward hypersensitivity, estrogen may gently increase their responsiveness.
The shift does not need to be dramatic.
A small increase in inflammatory signaling can be enough to produce noticeable symptoms.
Dysautonomia, particularly postural orthostatic tachycardia syndrome (POTS), shows a striking gender imbalance.
Women develop POTS far more frequently than men.
Researchers have been examining this difference for years, searching for physiological explanations. A 2025 study evaluated sex differences in orthostatic tolerance and cardiovascular regulation.⁴
Several patterns appear repeatedly.
Women demonstrate different hemodynamic responses during standing stress.
Blood volume regulation differs between sexes.
Cerebral blood flow responses vary during orthostatic challenges.
Hormonal environment likely contributes to these differences.
Estrogen interacts with several systems involved in autonomic regulation:
Vascular tone
Nitric oxide signaling
Baroreceptor sensitivity
Sympathetic nervous system activation
The vascular system behaves like an adjustable plumbing network. Blood vessels expand or tighten depending on signals from the autonomic nervous system.
Estrogen can influence that signaling balance.
Picture the autonomic nervous system as a pilot maintaining altitude during turbulence.
Small changes in vascular tone affect how blood pools in the legs.
Small changes in blood volume influence circulation to the brain.
Small changes in sympathetic signaling alter heart rate responses.
Standing upright becomes a complex physiological negotiation.
For someone whose autonomic system already operates close to its limits, even subtle hormonal changes can shift the balance.
This is not simple causation.
It is modulation.
Modulation becomes important when stability is fragile.
Zoom out far enough and the pattern begins to make biological sense.
Consider a system that may already contain several pressure points:
Connective tissue that is structurally delicate
An immune system prone to inflammatory dysregulation
An autonomic nervous system sensitive to vascular changes
Now layer in major hormonal transitions.
Puberty reshapes endocrine signaling across the body.
Pregnancy dramatically alters connective tissue chemistry.
Monthly estrogen fluctuations influence immune and vascular pathways.
Hormones do not design the architecture of these systems.
They influence the tension within them.
They adjust connective tissue remodeling, inflammatory signaling, vascular tone, and autonomic balance.
In a resilient system these adjustments occur quietly in the background.
In a vulnerable system the same adjustments can feel like the ground shifting beneath your feet.
The Floppy Files conversations often circle back to a similar theme.
Multiple biological systems interacting at once.
Immune signaling.
Connective tissue biology.
Autonomic regulation.
Hormonal modulation.
None of these elements operates in isolation. Each influences the others through overlapping biochemical pathways.
Hormones are not villains.
They are regulators.
When those regulators interact with systems that are already sensitive, the effects can become noticeable.
When large numbers of individuals report symptom shifts around puberty, pregnancy, hormonal cycles, trauma, or infection, investigating these mechanisms is not dramatic speculation.
It is responsible scientific curiosity.
The full answer may be complex.
The pattern, however, is difficult to ignore.
References:
-
Research examining estrogen’s role in tendon remodeling and extracellular matrix regulation. J Orthop Res. 2024.
-
Parker EA, et al. Menstrual cycle hormone relaxin and ACL injuries in female athletes: a systematic review. Iowa Orthop J. 2024.
-
McCallion A, et al. Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology. Front Immunol. 2022;13:961599.
-
Fitzgibbon-Collins LK, Pereira TJ, Edgell H. Women, orthostatic tolerance, and POTS: a narrative review. Auton Neurosci. 2025:103284.
This content is intended for educational purposes only and is not medical advice. It is not a substitute for individualized evaluation, diagnosis, or treatment. Always consult your qualified healthcare provider regarding your specific health concerns.